These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 38505170)

  • 1. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
    Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
    Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
    Jena L; McErlean E; McCarthy H
    Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
    Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
    Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in targeted drug delivery for the treatment of glioblastoma.
    Mao M; Wu Y; He Q
    Nanoscale; 2024 May; 16(18):8689-8707. PubMed ID: 38606460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management.
    Upadhaya PG; Pulakkat S; Patravale VB
    Drug Deliv Transl Res; 2020 Aug; 10(4):1044-1056. PubMed ID: 32221847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation of focused ultrasound for blood-brain barrier opening in glioma.
    Brighi C; Salimova E; de Veer M; Puttick S; Egan G
    J Control Release; 2022 May; 345():443-463. PubMed ID: 35337938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Gallego L; Ceña V
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions.
    Kumar N; Khurana B; Arora D
    Pharm Dev Technol; 2023 Dec; 28(10):1032-1047. PubMed ID: 37975846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
    Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
    J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.
    Arsiwala TA; Sprowls SA; Blethen KE; Adkins CE; Saralkar PA; Fladeland RA; Pentz W; Gabriele A; Kielkowski B; Mehta RI; Wang P; Carpenter JS; Ranjan M; Najib U; Rezai AR; Lockman PR
    Neoplasia; 2021 Jul; 23(7):676-691. PubMed ID: 34139452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.